Amoxivet is the generic form of antibiotics that are often prescribed as Morisot, Amoxil, Biomox, Dispermox, Trimox, and Wymox. It is commonly used to treat bacterial infections in the body such as gonorrhea, skin infections, tooth infections, ear infections, tonsillitis, pneumonia, bronchitis, urinary tract infections, and other forms of bacterial infections.
Amoxivet is not for everyone. A thorough medical history should be disclosed to your doctor prior to prescribing this medicament. Patients with a medical history that includes allergies to penicillin or cephalosporin, or a history of kidney disease, bowel disease, stomach disease, or intestinal disease may not be able to take Amoxivet or may require careful monitoring while undergoing treatment, depending on the severity of the patient's condition.
The American Food and Drug Administration has rated Amoxivet as a pregnancy risk category B. This means that this medicament is not expected to cause harm or birth defects in an unborn baby. Amoxivet does pass through the mother's breast milk, and while very few cases have been reported, there is a small risk to the nursing baby. Less than one half of a percent have reported yeast infections, diarrhea, or allergic reactions in nursing babies. Discuss with your doctor whether the benefits outweigh the risks prior to taking this medicament if you are pregnant or nursing, or likely to become pregnant.
As with most medicaments, there is a risk of side effects associated with Amoxivet, some of which are severe. A patient experiencing a serious side effect or an allergic reaction should immediately seek medical attention. Symptoms of an allergic reaction include facial skin edema, including skin edema of the lips, mouth, tongue, or throat, hives, and difficulty breathing. Other serious side effects, which require emergency medical attention, include unusual bleeding, easy bruising, or seizures. Seek immediate medical attention if you experience any of these side effects.
Less serious side effects typically do not require emergency medical attention but should be reported to your doctor. Patients are encouraged to report all side effects to their doctor. Less serious side effects include white patches on the tongue, mild nausea, vomiting, diarrhea, stomach ache, vaginal yeast infection, or a black “hairy” tongue, or a sore mouth and tongue. Less serious side effects can usually be reduced to a tolerable level simply by reducing the dose of Amoxivet.
Amoxivet should be taken exactly as prescribed by the physician. If the patient misses a dose, the dose should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped to avoid the potential of an overdose. If an overdose is suspected, the patient should seek immediate medical attention. Overdose includes symptoms such as pain, twitching, weakness, pain in the fingers or toes, muscle spasm, loss of feeling in the fingers or toes, confusion, agitation, seizures, coma, or death. If you experience any of these symptoms, seek immediate medical attention.
There is a risk of negative drug interaction associated with Amoxivet. A thorough medical history should be given prior to taking this medicament. Patients also need to talk with their doctor before taking any new medicaments, including over the counter medicaments and herbal remedies. Medications with known negative drug interactions with Amoxivet include any other antibiotic, methotrexate, probenecid, and allopurinol.
Patients should take the entire prescription as directed by the physician, even if their symptoms subside. Patients that end their treatment of Amoxivet early run the risk of a relapse and can be more severe and more resistant to antibiotics. The chronic or overly frequent use of antibiotics can lead to the body's tolerance of the medicament, rendering it ineffective.
Amoxivet has the following structural formula:
• Molecular formula of amoxivet is C16H19N3O5S
• Chemical IUPAC Name is 7-[2-amino-2-(4-hydroxyphenyl)-acetyl]amino-3,3-dimethyl-6- oxo-2-thia-5-azabicyclo[3.2.0]heptane-4-carboxylic acid
• Molecular weight is 365.405 g/mol
• Amoxivet available : 500mg capsules, 400mg chew tabs, 200mg/5ml suspension 100ml bottle, 250mg/5ml suspension 100ml bottle, 400mg/5ml suspension 100ml bottle, 125mg/5ml suspension 150ml bottle, 250mg/5ml suspension 150ml bottle, 50mg/ml suspension 30ml bottle, 400mg/5ml suspension 50ml bottle, 400mg/5ml suspension 75ml bottle, 500mg tablets, 875mg tablets
©2007-2017 Medicalook.com All rights reserved